MAPT and proteostasis deficiencies: Furthermore, improved understanding of the roles of APOE2 in other diseases, such as cerebrovascular diseases and different proteinopathies, including tau, TDP-43, and α-Syn pathologies, will aid in the comprehensive assessment of safety regarding APOE2-targeted therapeutics for AD.